Cancer Treatment News and Research

RSS

Fresenius Medical Care to acquire Euromedic's dialysis service business

Fresenius Medical Care AG & Co. KGaA, the world's largest provider of dialysis products and services, today announced the signing of a purchase agreement to acquire International Dialysis Centers ("IDC"), Euromedic International's ("Euromedic") dialysis service business.

4 Jan 2011

14th World Conference on Lung Cancer: Online registration opens

Online registration opens today for the 14th World Conference on Lung Cancer, which will be held in Amsterdam, The Netherlands, from July 3-7, 2011.

4 Jan 2011

Personality characteristics impact psychological recovery after breast cancer treatment

Certain personality traits are linked to higher quality-of-life scores in breast cancer patients who undergo breast reconstruction after mastectomy, reports a study in the January issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.

4 Jan 2011

New options in fertility preservation for oncology patients

Many young people who've just learned that they have cancer also are told that the therapies that may save their lives could rob them of their ability ever to have children. Infertility caused by chemotherapy and radiation affects a sizable population: Of the 1.5 million people diagnosed with cancer in 2009, nearly 10 percent were still in their reproductive years.

4 Jan 2011

Mercator, Pepscan enter multi-program cancer research collaboration

Mercator Therapeutics, the first biopharmaceutical company to systematically use in vivo phage display technology to develop novel cancer drugs and Pepscan Therapeutics, a world leader in protein mimicry technologies for improved therapeutic peptides and anti-GPCR antibodies, today announced a multi-program research collaboration. The companies will collaborate to optimize Mercator's 'Homing Peptides' using Pepscan's proprietary CLIPS technology.

4 Jan 2011

Target enrollment reached in belinostat Phase 2 study in Carcinoma of Unknown Primary

Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, announced today that the target enrollment has been reached for the Phase 2 study of belinostat in Carcinoma of Unknown Primary (CUP).

23 Dec 2010

In State budgets, Medicaid goes under the knife; Costs high for Florida Medicaid's doctor-immunity plan; N.J. practices to launch ACOs

Governors nationwide are taking a scalpel to Medicaid, the jointly run state and federal health-care program for 48 million poor Americans, half of whom are children. The single biggest expense for states, Medicaid consumes about 22 percent of their total $1.6 trillion in expenditures, more than what is allocated to elementary and secondary education, according to a National Governors Association report.

23 Dec 2010

NCI grants U-M Cancer Center $10.7M for study of colorectal and pancreatic cancer

The University of Michigan Comprehensive Cancer Center has received a five-year $10.7 million grant from the National Cancer Institute to study colorectal and pancreatic cancer.

23 Dec 2010

Gold nanoparticles show great potential for tumour targeted drug delivery

The World Gold Council (WGC) is delighted with the successful phase 1 clinical trial of a unique nanomedicine that uses nanoparticles of gold as the core of a delivery system for tumour targeted drug delivery.

22 Dec 2010

UH scientist evaluates microRNAs as potential treatment strategy for ovarian cancer

The day when an ovarian cancer patient can treat her tumor with a single, painless pill instead of a toxic drug cocktail is the ultimate goal of the pioneering research of a University of Houston scientist.

22 Dec 2010

Wyden's cancer treatment highlights debate over health care cost vs. personal choice

Sen. Ron Wyden had surgery for prostate cancer Monday, putting himself — through no fault of his own — in the middle of a debate about diagnosis, treatment and bending the cost curve.

22 Dec 2010

URI, R.I. Hospital to offer medical physics degree

Students interested in physics and medicine will be able to combine disciplines to become medical physicists and enter an expanding field that offers multiple career opportunities and salaries that start with six figures.

21 Dec 2010

Damon Runyon Cancer Research Foundation names first recipients of Frey Award for Breakthrough Scientists

The Damon Runyon Cancer Research Foundation, a non-profit organization focused on supporting innovative early career researchers, named the first recipients of the Dale F. Frey Award for Breakthrough Scientists. This new award provides additional funding to scientists completing a prestigious Damon Runyon Fellowship Award who have greatly exceeded the Foundation's highest expectations and are most likely to make paradigm-shifting breakthroughs that transform the way we prevent, diagnose and treat cancer.

21 Dec 2010

Study: Chemotherapy can improve survival rate in older adolescents with leukemia

Research led by St. Jude Children-s Research Hospital investigators will likely impact how acute lymphoblastic leukemia is treated in young adults and shows older adolescent age does not dictate worse outcomes against the most common childhood cancer.

21 Dec 2010

New study finds racial, ethnic disparities in cancer treatment

Black people with early stage liver cancer were more likely than white patients to die from their disease, according to a new study from the University of Michigan Comprehensive Cancer Center.

21 Dec 2010

U of A student wins annual master's thesis competition for research on light-sensitive drug for prostate cancer

The future of cancer treatment and a University of Alberta graduate student's personal career prospects are looking bright. Weiyang Liu beat competitors from 80 of the best university graduate schools in western North America with his master's thesis on the use of a light-sensitive drug to treat prostate cancer.

20 Dec 2010

FDA moves to curb Avastin's approval for breast cancer

The Food and Drug administration on Thursday revoked its approval of Roche drug Avastin for the treatment of breast cancer. The agency's action, based on findings that did not confirm that the medicine helped patients with this disease, has drawn criticism from patients and politicians.

20 Dec 2010

GSI scientists irradiate human tumor tissue to enhance ion beam therapy

Cancer treatment with ion beams developed at GSI is characterized by an excellent cure rate and only minor side effects. The therapy has been routinely in use for a little over one year.

20 Dec 2010

Today's Opinions: Cucinelli argues for quickly moving Va. case to the Supreme Court; Unraveling Medicaid leaves a big gap; Taking away a cancer treatment

It's hard not to laugh at the cries over the "injustice" of forcing people to buy coverage. Working Americans are already forced to buy health coverage - but for others. They can't choose not to pay the Medicare payroll tax. They can't even make a deal with the government, promising, "I will forgo all future Medicare benefits if I can be freed from the Medicare payroll tax" (Froma Harrop, 12/16).

17 Dec 2010

Elsevier Foundation's new library grants focus on telemedicine, HIV/AIDS videos and Egyptian cancer database

The Elsevier Foundation has announced the 2010 recipients of grants under its Innovative Libraries in Developing Countries program, committing over $300,000 to support the work of libraries in developing countries. The 2010 grant recipients were selected from 260 proposals worldwide for their innovation and potential for impact in the developing world. The Innovative Libraries program supports capacity-building projects in the science, technology and medicine library training, education, infrastructure, digitization and the preservation of information.

17 Dec 2010

Cancer Treatment News and Research

Fresenius Medical Care to acquire Euromedic's dialysis service business

14th World Conference on Lung Cancer: Online registration opens

Personality characteristics impact psychological recovery after breast cancer treatment

New options in fertility preservation for oncology patients

Mercator, Pepscan enter multi-program cancer research collaboration

Target enrollment reached in belinostat Phase 2 study in Carcinoma of Unknown Primary

In State budgets, Medicaid goes under the knife; Costs high for Florida Medicaid's doctor-immunity plan; N.J. practices to launch ACOs

NCI grants U-M Cancer Center $10.7M for study of colorectal and pancreatic cancer

Gold nanoparticles show great potential for tumour targeted drug delivery

UH scientist evaluates microRNAs as potential treatment strategy for ovarian cancer

Wyden's cancer treatment highlights debate over health care cost vs. personal choice

URI, R.I. Hospital to offer medical physics degree

Damon Runyon Cancer Research Foundation names first recipients of Frey Award for Breakthrough Scientists

Study: Chemotherapy can improve survival rate in older adolescents with leukemia

New study finds racial, ethnic disparities in cancer treatment

U of A student wins annual master's thesis competition for research on light-sensitive drug for prostate cancer

FDA moves to curb Avastin's approval for breast cancer

GSI scientists irradiate human tumor tissue to enhance ion beam therapy

Today's Opinions: Cucinelli argues for quickly moving Va. case to the Supreme Court; Unraveling Medicaid leaves a big gap; Taking away a cancer treatment

Elsevier Foundation's new library grants focus on telemedicine, HIV/AIDS videos and Egyptian cancer database

Cancer Research eBook

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News